Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion type Assertion NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_head.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion description "[The mRNA level for cannabinoid receptor type 2 (CB2) was significantly increased in AD-PBMCs as compared to healthy subjects (mean���SE of arbitrary units: 0.34���0.03 vs. 0.23���0.02 in autistic children and healthy subjects, respectively), whereas CB1 and fatty acid amide hydrolase mRNA levels were unchanged.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion evidence source_evidence_literature NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion SIO_000772 23585028 NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion wasDerivedFrom befree-2016 NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.
- NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_assertion wasGeneratedBy ECO_0000203 NP1069157.RAsJW3cV6DjBC7HqnEPrVUCgJV0M_TlxXZ9n12us-0yiQ130_provenance.